
Protalix BioTherapeutics, Inc.
PLXNYSECIK 1006281HealthcareFiscal year ends Dec 31
Reports and events: 399 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2015-02-0207:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-15-005162 |
| 2015-01-0807:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-15-001279 |
| 2015-01-0507:06 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-15-000265 |
| 2014-11-1207:31 ET | 8-K | 5.07 Shareholder vote results | 0001144204-14-066830 |
| 2014-11-1016:32 ET | 10-Q | Quarterly reportPeriod 2014-09-30 | 0001144204-14-066530 |
| 2014-10-0916:30 ET | DEF 14A | Proxy statementPeriod 2014-11-10 | 0001144204-14-060401 |
| 2014-09-2916:30 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001144204-14-058399 |
| 2014-09-1713:34 ET | SC 13D/A | Ownership report, active investor, amended | 0001178913-14-002958 |
| 2014-08-2906:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-14-053151 |
| 2014-08-2810:21 ET | SC 13D/A | Ownership report, active investor, amended | 0001178913-14-002789 |
| 2014-08-0716:30 ET | 10-Q | Quarterly reportPeriod 2014-06-30 | 0001144204-14-047741 |
| 2014-07-2416:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001144204-14-044715 |
| 2014-06-2707:17 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-14-039944 |
| 2014-06-1807:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-14-038202 |
| 2014-06-1308:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001144204-14-037449 |
| 2014-05-3007:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-14-034381 |
| 2014-05-2207:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-14-032962 |
| 2014-05-0816:31 ET | 10-Q | Quarterly reportPeriod 2014-03-31 | 0001144204-14-028653 |
| 2014-03-1316:32 ET | 10-K | Annual reportPeriod 2013-12-31 | 0001144204-14-015468 |
| 2014-02-1207:43 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-14-007755 |
| 2014-01-1307:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-14-001804 |
| 2013-11-1206:10 ET | 8-K | 5.07 Shareholder vote results | 0001144204-13-060136 |
| 2013-11-0716:43 ET | 10-Q | Quarterly reportPeriod 2013-09-30 | 0001144204-13-059668 |
| 2013-10-1506:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-13-055039 |
| 2013-09-2019:04 ET | DEF 14A | Proxy statementPeriod 2013-11-07 | 0001144204-13-051645 |
| 2013-09-1817:22 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-13-051455 |
| 2013-09-1116:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-13-050235 |
| 2013-09-0316:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001144204-13-048995 |
| 2013-08-0816:31 ET | 10-Q | Quarterly reportPeriod 2013-06-30 | 0001144204-13-043990 |
| 2013-06-2015:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-13-035824 |
| 2013-06-1906:02 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-13-035540 |
| 2013-06-1207:40 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-13-034416 |
| 2013-05-0917:15 ET | 10-Q | Quarterly reportPeriod 2013-03-31 | 0001144204-13-027499 |
| 2013-04-2907:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-13-024427 |
| 2013-04-0207:43 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-13-019478 |
| 2013-03-1815:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-13-015768 |
| 2013-03-0709:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-13-013432 |
| 2013-02-2816:32 ET | 10-K | Annual reportPeriod 2012-12-31 | 0001144204-13-012065 |
| 2013-02-1307:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-13-007983 |
| 2013-02-0516:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-13-006107 |
| 2012-12-1006:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-12-067055 |
| 2012-12-0607:51 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-12-066660 |
| 2012-11-0716:06 ET | 10-Q | Quarterly reportPeriod 2012-09-30 | 0001144204-12-060041 |
| 2012-11-0112:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-12-058841 |
| 2012-09-2706:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-12-053080 |
| 2012-08-1307:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-12-044622 |
| 2012-08-0907:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001144204-12-043820 |
| 2012-08-0317:23 ET | 10-Q | Quarterly reportPeriod 2012-06-30 | 0001144204-12-042862 |
| 2012-07-1816:51 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001144204-12-040015 |
| 2012-07-0207:34 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-12-037523 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.